Updated: January 17, 2026
Alternatives to Pylera If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- What Makes Pylera Unique (and Hard to Replace Exactly)?
- Alternative 1: Traditional Bismuth Quadruple Therapy (Same Drugs, Separate Pills)
- Alternative 2: Talicia (Rifabutin + Omeprazole + Amoxicillin)
- Alternative 3: Voquezna (Vonoprazan-Based Regimens)
- Alternative 4: Prevpac (Clarithromycin Triple Therapy)
- How to Discuss Alternatives With Your Doctor
Can't find Pylera at your pharmacy? Several effective H. pylori treatments can replace it. Here are your best alternatives and how to talk to your doctor about them.
If your pharmacy doesn't have Pylera in stock — or if the cost is simply out of reach — the good news is that several effective alternatives exist for treating Helicobacter pylori (H. pylori) infections. The 2024 American College of Gastroenterology (ACG) guidelines recognize multiple first-line and salvage treatment options, so your doctor has flexibility.
This guide covers the most effective alternatives to Pylera, how they compare, and what you should discuss with your prescriber.
What Makes Pylera Unique (and Hard to Replace Exactly)?
Pylera's convenience comes from combining three drugs — bismuth subcitrate potassium, metronidazole, and tetracycline — into a single capsule. Patients take 3 capsules four times daily for 10 days alongside omeprazole. The all-in-one format reduces pill burden and simplifies the regimen, which improves adherence.
There is currently no other drug that combines all three of these exact ingredients into one capsule. However, effective alternatives exist — either by prescribing the same ingredients separately, or by using a completely different H. pylori eradication regimen.
Alternative 1: Traditional Bismuth Quadruple Therapy (Same Drugs, Separate Pills)
This is the most direct alternative to Pylera. Your doctor can prescribe the same three active ingredients — bismuth, metronidazole, and tetracycline — as separate generic medications, plus a proton pump inhibitor (PPI) like omeprazole. This is sometimes called "traditional bismuth quadruple therapy" or BQT.
Bismuth subsalicylate (generic / OTC as Pepto-Bismol) — widely available at very low cost
Metronidazole (generic Flagyl) — inexpensive and widely available
Tetracycline HCl (generic) — generally available, though cost and availability can vary by pharmacy
Omeprazole (generic Prilosec) — inexpensive and OTC-available
Pros: Same active ingredients as Pylera; all generics are widely available; total cost is typically far lower than Pylera.
Cons: More pills to take each day, which can affect adherence. The standard course is 14 days rather than 10.
Alternative 2: Talicia (Rifabutin + Omeprazole + Amoxicillin)
Talicia is a newer FDA-approved combination capsule (approved 2019) containing rifabutin, omeprazole, and amoxicillin. It uses entirely different antibiotics than Pylera, making it especially useful if you have metronidazole or tetracycline resistance, or if prior H. pylori treatments have failed.
Pros: Effective for metronidazole-resistant H. pylori; good option after treatment failure; FDA-approved combination capsule.
Cons: Very expensive (over $1,000 without insurance); requires amoxicillin tolerance (not suitable for penicillin-allergic patients); rifabutin can cause serious side effects including neutropenia.
Alternative 3: Voquezna (Vonoprazan-Based Regimens)
Vonoprazan (Voquezna) is a newer acid-suppressing medication (a potassium-competitive acid blocker, or PCAB) that received FDA approval for H. pylori eradication in 2022. It comes in two pre-packaged regimens: Voquezna Triple Pak (vonoprazan + clarithromycin + amoxicillin) and Voquezna Dual Pak (vonoprazan + amoxicillin).
Pros: Stronger acid suppression than standard PPIs; clinical trials showed superior eradication rates compared to clarithromycin-based triple therapy; once-daily dosing with Dual Pak.
Cons: Expensive and relatively new; Triple Pak is most effective when clarithromycin susceptibility is confirmed; Dual Pak relies on single-antibiotic coverage.
Alternative 4: Prevpac (Clarithromycin Triple Therapy)
Prevpac contains lansoprazole, amoxicillin, and clarithromycin. It was once the standard first-line H. pylori treatment, but the 2024 ACG guidelines have moved away from clarithromycin-based therapy as a first-line option due to rising resistance rates. In the U.S., more than 30% of H. pylori strains are now clarithromycin-resistant, which significantly reduces eradication rates.
Pros: Pre-packaged convenience; widely available; well-tolerated; generally lower cost than Pylera.
Cons: No longer recommended as empiric first-line therapy due to high clarithromycin resistance; not appropriate if you've previously used macrolide antibiotics.
How to Discuss Alternatives With Your Doctor
When you call your doctor to report that Pylera isn't available or affordable, come prepared with this information:
Which pharmacies you've tried (and that none had Pylera in stock)
Whether you have a penicillin allergy (rules out Talicia and vonoprazan dual therapy)
Whether you have previously used clarithromycin or macrolide antibiotics (affects suitability of Prevpac)
Whether this is your first H. pylori treatment (first-line) or you've previously been treated and the infection persisted (salvage therapy)
Remember, you don't have to stay stuck. If Pylera isn't available, effective H. pylori eradication is still within reach. And if you're still trying to find Pylera itself, medfinder can help you locate pharmacies near you that have it in stock.
Frequently Asked Questions
The most direct alternative is traditional bismuth quadruple therapy: prescribing the same three active ingredients (bismuth, metronidazole, tetracycline) as separate generics plus omeprazole. This is the same treatment — just not combined in one capsule — and is typically much cheaper. For patients who need a different drug approach, Talicia or vonoprazan-based regimens (Voquezna) are FDA-approved options.
Yes. Bismuth (as bismuth subsalicylate in OTC Pepto-Bismol or prescription bismuth subcitrate), metronidazole (generic Flagyl), and tetracycline HCl are all available as separate medications. Together with a PPI like omeprazole, this traditional bismuth quadruple therapy achieves similar H. pylori eradication rates as Pylera, though the standard course is 14 days instead of 10.
Talicia (rifabutin/omeprazole/amoxicillin) is an excellent option for patients who have failed other H. pylori treatments or have metronidazole resistance. However, it's very expensive (over $1,000 without insurance) and is not appropriate for patients with penicillin allergies. It's best reserved for treatment-experienced patients rather than as a first-line substitution.
Vonoprazan-based regimens (Voquezna Triple Pak or Dual Pak) have shown strong H. pylori eradication rates in clinical trials, sometimes outperforming older PPI-based regimens. The 2024 ACG guidelines recognize them as an empiric alternative. However, they're relatively new, can be expensive, and the Triple Pak is most effective when the strain is clarithromycin-sensitive.
Clarithromycin triple therapy (Prevpac: lansoprazole + amoxicillin + clarithromycin) is no longer recommended as empiric first-line H. pylori treatment by the 2024 ACG guidelines due to rising clarithromycin resistance rates exceeding 30% in the U.S. It may be used if clarithromycin susceptibility has been confirmed through testing.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Pylera also looked for:
More about Pylera
30,038 have already found their meds with Medfinder.
Start your search today.





